You are here: Industry Insights > liver disease

News List

OrbiMed, Vivo lead $80M B round for Terns Pharma fiercebiotech
November 02, 2018
Terns Pharmaceuticals has bagged $80 million to bankroll a pipeline of drugs for nonalcoholic steatohepatitis (NASH). The company, which has one foot in San Mateo, California...
The €34 million project for assessing liver disease biospectrumasia
November 24, 2017
The €34 million project is co-ordinated by Newcastle University, working closely with the lead EFPIA partner, Pfizer Ltd.
Use of antacids found to promote liver disease pharmafile
October 11, 2017
A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid reflux medications and chronic liver disease.
Common acid reflux medications promote chronic liver disease europeanpharmaceuticalreview
October 11, 2017
Researchers have discovered evidence that stomach acid suppression alters specific gut bacteria in a way that promotes liver injury and progression of three types of chronic liver disease…